Showing results (271-280 of 329) with videos related to

Sort By:
Pageof 33
Cancer Chemotherapy and Pharmacology|January 1, 1992
Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B studyJ B Hargis, J R Anderson, K J Propert, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promotersK A Lee, T Y Hai, L SivaRaman, et al.
Nature Biotechnology|January 3, 2001
Rapid identification and characterization of hammerhead-ribozyme inhibitors using fluorescence-based technologyA Jenne, J S Hartig, N Piganeau, et al.
Seminars in Oncology|June 1, 1994
Nonoperative management of non-small cell lung cancer: the current cancer and leukemia group B experienceM R Green, M P Kosty, J J Muscato, et al.
American Journal of Clinical Oncology|October 1, 1992
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group BA P Lyss, M C Perry, M Goutsou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902C M Rocha-Lima, J E Herndon, M E Lee, et al.
Cancer|September 1, 1993
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancerH Kreisman, A Lisbona, L Olson, et al.
The Annals of Thoracic Surgery|July 27, 1999
Lung cancer staging and treatment in multidisciplinary trials: Cancer and Leukemia Group B cooperative group approach. Thoracic Surgeons of CALGBM J Krasna, C E Reed, W C Nugent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Trimetrexate in malignant mesothelioma: A Cancer and Leukemia Group B Phase II studyN J Vogelzang, L B Weissman, J E Herndon, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B studyS L Graziano, F H Valone, J E Herndon, et al.
Pageof 33